Our mission is to develop herpesvirus-based animal vaccines to protect against infectious diseases. 

Vaccine Solutions for the 21st Century

The Vaccine Group (TVG) is using recombinant viral vector technology to develop new vaccines for use in animals to tackle diseases falling into two broad categories:

  • Zoonotic diseases, such as COVID-19, Ebola and Lassa fever, which jump from animals to humans;


  • Diseases such as bovine tuberculosis, porcine reproductive & respiratory syndrome and  African Swine Fever which have a high impact on production of economically important livestock. 

Our Pipeline

We are creating vaccine delivery platforms for viral and bacterial pathogens to address a growing number of disease issues in animals:

• Bovine tuberculosis
• Bovine mastitis
• Streptococcus suis
• African swine fever virus
• Porcine reproductive and respiratory syndrome

Leadership Team


Jeremy Salt, PhD


Michael Jarvis, PhD

Founder & CSO

Matthew White Profile

Matthew White


Prof. Robert Fern


Latest News